Quantum field theory (QFT)-enabled sensor networks are revolutionizing precision disease detection by exploiting quantum–classical correlations to achieve sensitivity and specificity beyond classical limits. Their diagnostic power, however, depends critically on machine learning (ML) for denoising, fusion, and interpretation of high-dimensional, entangled, and multimodal data streams. This review integrates advances at the ML–QFT interface across four pillars: (i) sensing foundations—NV-diamond and optically pumped magnetometry, cavity optomechanics, and quantum plasmonic or photonic systems; (ii) learning methods—physics-informed preprocessing (e.g., VAEs, diffusion models, PINNs), representation learning for sensor arrays and time series (GNNs, transformers), and hybrid quantum–classical architectures; (iii) applications—ultrasensitive pathogen detection, cancer biomarker profiling, neurodegenerative disease monitoring, and epidemiological surveillance; and (iv) cross-cutting enablers—adaptive calibration, federated and transfer learning, and explainable AI for clinical assurance. A practical ML–QFT co-design framework is presented, mapping model classes to sensor physics and deployment settings (edge/on-sensor versus cloud). An evaluation checklist coupling metrological and ML metrics—limit of detection, SNR uplift, calibration stability, latency, robustness under data shift, and interpretability—is proposed for benchmarking. Literature evidence shows that physics-aligned representations and hybrid learners consistently enhance performance in low-SNR and data-scarce regimes, though challenges remain from decoherence, drift, and scalability. The review concludes with a roadmap toward open benchmarks, quantum-networked distributed sensing, multiscale modeling linking molecular and population data, and certifiable, explainable ML pipelines—positioning ML not just as post-hoc analytics but as a design logic for globally distributed, self-calibrating quantum diagnostic ecosystems.
Quantum field theory (QFT)-enabled sensor networks are revolutionizing precision disease detection by exploiting quantum–classical correlations to achieve sensitivity and specificity beyond classical limits. Their diagnostic power, however, depends critically on machine learning (ML) for denoising, fusion, and interpretation of high-dimensional, entangled, and multimodal data streams. This review integrates advances at the ML–QFT interface across four pillars: (i) sensing foundations—NV-diamond and optically pumped magnetometry, cavity optomechanics, and quantum plasmonic or photonic systems; (ii) learning methods—physics-informed preprocessing (e.g., VAEs, diffusion models, PINNs), representation learning for sensor arrays and time series (GNNs, transformers), and hybrid quantum–classical architectures; (iii) applications—ultrasensitive pathogen detection, cancer biomarker profiling, neurodegenerative disease monitoring, and epidemiological surveillance; and (iv) cross-cutting enablers—adaptive calibration, federated and transfer learning, and explainable AI for clinical assurance. A practical ML–QFT co-design framework is presented, mapping model classes to sensor physics and deployment settings (edge/on-sensor versus cloud). An evaluation checklist coupling metrological and ML metrics—limit of detection, SNR uplift, calibration stability, latency, robustness under data shift, and interpretability—is proposed for benchmarking. Literature evidence shows that physics-aligned representations and hybrid learners consistently enhance performance in low-SNR and data-scarce regimes, though challenges remain from decoherence, drift, and scalability. The review concludes with a roadmap toward open benchmarks, quantum-networked distributed sensing, multiscale modeling linking molecular and population data, and certifiable, explainable ML pipelines—positioning ML not just as post-hoc analytics but as a design logic for globally distributed, self-calibrating quantum diagnostic ecosystems.
The rapid advancements in artificial intelligence (AI) and quantum computing have catalyzed an unprecedented shift in the methodologies utilized for healthcare diagnostics and treatment optimization. This research paper explores the integration of quantum neural networks (QNNs) with classical machine learning (ML) algorithms to enhance diagnostic accuracy, facilitate personalized treatment plans, and predict patient outcomes with a higher degree of precision. Quantum neural networks, leveraging the principles of quantum mechanics such as superposition, entanglement, and quantum parallelism, have demonstrated the potential to perform complex computations more efficiently than classical counterparts. When coupled with established machine learning algorithms, QNNs can overcome traditional limitations in data processing, enabling more sophisticated models capable of uncovering intricate patterns in large and high-dimensional datasets. Machine learning, with its vast applications in the medical field, has long been instrumental in improving diagnostics and tailoring treatment regimens to patient-specific characteristics. However, despite significant advancements, classical ML approaches face substantial challenges, particularly in terms of computational complexity and the ability to process large-scale, multi-modal healthcare data effectively. Quantum neural networks address these challenges by introducing quantum computational paradigms that facilitate exponentially faster processing, allowing for real-time analysis of vast and complex datasets. The synergy between QNNs and ML algorithms introduces novel approaches that are poised to revolutionize predictive analytics in healthcare, optimizing patient outcomes and enabling highly personalized treatment plans. A key aspect of integrating quantum neural networks into machine learning frameworks is the potential for improved precision in diagnostic systems. Traditional diagnostic procedures often rely on predefined models that may overlook nuanced correlations within patient data. Quantum neural networks, with their ability to represent and process data in a quantum space, provide a more robust framework that can adaptively learn from intricate relationships in patient information. For instance, QNNs can significantly enhance the efficacy of disease detection algorithms, such as those used for identifying early-stage cancers or predicting the onset of chronic conditions like diabetes and heart disease, by offering superior pattern recognition capabilities. Furthermore, QNNs combined with classical machine learning architectures facilitate the creation of hybrid models that harness the strengths of both approaches, leading to diagnostic tools that are not only more precise but also more adaptive to varied data sources. The integration of QNNs with machine learning extends beyond diagnostics to personalized treatment optimization. Traditional treatment planning methodologies, including rule-based and data-driven ML models, often face difficulties in accounting for the multifaceted nature of patient data and individual variability. Quantum neural networks enhance this process by leveraging quantum algorithms that provide an efficient search space for complex treatment optimization problems, allowing for a more detailed understanding of patient responses and potential treatment outcomes. The ability of QNNs to perform parallel processing enables the assessment of a wide range of treatment scenarios simultaneously, leading to more accurate predictions regarding patient reactions to specific drugs, therapies, or medical interventions. This facilitates an adaptive approach that can recommend personalized treatment regimens based on comprehensive patient profiles, ultimately enhancing patient outcomes and reducing the likelihood of adverse drug reactions. In addition to enhancing diagnostics and treatment recommendations, quantum neural networks show promise in forecasting patient outcomes by offering a more robust analysis of longitudinal patient data. Forecasting models that leverage the combined power of quantum and classical algorithms can process historical data more rapidly, allowing healthcare providers to anticipate potential health issues and intervene earlier. For example, predictive models utilizing QNNs can anticipate patient deterioration in critical care settings, facilitating timely interventions that mitigate risks and improve survival rates. Such predictive models can be instrumental in managing chronic diseases, monitoring recovery trajectories, and optimizing resource allocation within healthcare systems, thus contributing to overall efficiency and better resource management. Despite the promising capabilities of integrating QNNs with ML algorithms, there are notable challenges that need to be addressed to fully realize their potential. The practical implementation of quantum algorithms in a healthcare context faces hurdles related to hardware limitations, the need for high fidelity in quantum states, and the scalability of quantum systems to handle real-world clinical data. Additionally, the hybrid nature of combining classical and quantum approaches requires sophisticated algorithms that can bridge the gap between quantum computation and classical data processing pipelines. Solutions to these challenges may include advancements in quantum hardware, such as the development of more stable qubits and noise reduction techniques, as well as the optimization of hybrid algorithms that leverage both classical machine learning and quantum computing capabilities effectively. The exploration of quantum neural networks for healthcare applications also necessitates rigorous ethical considerations, particularly in ensuring data privacy and security. The incorporation of quantum computing must comply with healthcare data protection regulations, and quantum algorithms must be designed to maintain patient confidentiality while processing sensitive health data. Moreover, the interpretability of quantum models poses challenges that could hinder their acceptance in clinical practice. Advances in explainable AI and quantum algorithm transparency are crucial to foster trust among healthcare professionals and patients alike. Integration of quantum neural networks with classical machine learning models represents a transformative approach that could significantly advance healthcare diagnostics, personalized treatment strategies, and patient outcome prediction. By harnessing the computational advantages offered by quantum systems and the flexibility of machine learning algorithms, healthcare applications can achieve a new level of precision and adaptability. Despite current challenges, continued research into quantum algorithms, quantum hardware development, and hybrid computational models promises substantial strides in overcoming these limitations. The synergy between QNNs and ML algorithms could ultimately lead to more effective, personalized, and efficient healthcare solutions, ushering in a new era of data-driven medical care characterized by increased diagnostic accuracy and improved treatment outcomes. As the field evolves, interdisciplinary collaboration between quantum physicists, computer scientists, and healthcare professionals will be vital to unlock the full potential of these innovative computational techniques and bring them to mainstream clinical use.
Artificial Intelligence (AI) is revolutionizing diagnostics by enhancing the capabilities of quantum imaging (QI) and quantum sensors (QS) in healthcare. By leveraging AI-driven algorithms, QI achieves superior image resolution, noise reduction, and real-time data analysis, enabling precise visualization of biological structures and early disease detection. AI’s pattern recognition capabilities facilitate the identification of subtle biomarkers and anomalies critical for diagnosing complex conditions, such as cancer and neurodegenerative diseases. Quantum mechanics underpins these advancements, driving breakthroughs in biosensing through quantum dots (QDs), plasmonic biosensors, and non-classical light, which enhance sensitivity and precision. Advanced techniques like quantum Raman spectroscopy and nitrogen-vacancy (NV) center-based sensors enable cutting-edge molecular detection and diagnostics applications. Furthermore, AI optimizes QS functionality, improving the accuracy of physiological and molecular measurements essential for non-invasive diagnostics. Integrating AI with QI systems reduces operational complexity, accelerates diagnostic workflows, and supports multimodal imaging approaches for comprehensive patient assessments. This review demonstrates the synergy between AI and quantum technologies, representing a transformative leap in medical diagnostics, offering unprecedented precision, speed, and accessibility for improved healthcare outcomes.
This review explores the integration of quantum machine learning (QML) algorithms into real-time epidemic surveillance systems and health policy simulation frameworks. As conventional machine learning models face scalability and interpretability challenges with high-dimensional epidemiological data, QML offers a transformative paradigm by leveraging quantum computing principles to enhance pattern recognition, data compression, and forecasting precision. The study examines emerging QML architectures and their application to real-time tracking of infectious diseases, anomaly detection in public health datasets, and dynamic modeling of transmission patterns. Additionally, it assesses the role of QML in simulating the impact of health interventions, policy shifts, and behavioral dynamics on epidemic trajectories. Emphasis is placed on multi-modal data integration from genomics, environmental monitoring, and mobility trends to refine predictive accuracy. Key implementation challenges—such as quantum decoherence, algorithmic instability, regulatory constraints, and limited access to quantum hardware—are critically analyzed. The paper concludes by proposing a roadmap for the adoption of hybrid quantum-classical frameworks and policy-informed computational modeling to strengthen global epidemic preparedness and responsive health governance.
This review explores the integration of quantum machine learning (QML) algorithms into real-time epidemic surveillance systems and health policy simulation frameworks. As conventional machine learning models face scalability and interpretability challenges with high-dimensional epidemiological data, QML offers a transformative paradigm by leveraging quantum computing principles to enhance pattern recognition, data compression, and forecasting precision. The study examines emerging QML architectures and their application to real-time tracking of infectious diseases, anomaly detection in public health datasets, and dynamic modeling of transmission patterns. Additionally, it assesses the role of QML in simulating the impact of health interventions, policy shifts, and behavioral dynamics on epidemic trajectories. Emphasis is placed on multi-modal data integration from genomics, environmental monitoring, and mobility trends to refine predictive accuracy. Key implementation challenges—such as quantum decoherence, algorithmic instability, regulatory constraints, and limited access to quantum hardware—are critically analyzed. The paper concludes by proposing a roadmap for the adoption of hybrid quantum-classical frameworks and policy-informed computational modeling to strengthen global epidemic preparedness and responsive health governance.
Prompt diagnosis of disease is a strong driver for decreasing mortality, improving patient care and healthcare expenditures. Classical machine learning (ML), which has shown great potential in bolstering predictive modeling throughout oncology, cardiology, and neurology, runs the risk of excessive data dimensionality along with high computational complexity. Quantum computing is an exciting new paradigm for computation that takes advantage of superposition and entanglement which can be beneficial in learning patterns in high-dimensional spaces and for kernel-based learning. This review provides a systematic summary of the preliminary work on quantum machine learning (QML) with empirical applications to early disease diagnosis, while emphasizing its theoretical foundations, algorithmic developments and application in healthcare. We scope the conversation on quantum support vector machines, variational quantum classifiers, quantum kernels and hybrid architectures for a quantum classical. We also examine current hardware limitations in the NISQ era and assess how close these methods are to being ready for translation into public health applications. Although widespread clinical application is still far away, hybrid QML approaches are finding utility in low-data and high-complexity settings. We conclude with a discussion of research challenges, regulation and strategy towards realizing such quantum-enhanced precision diagnostics through U.S. public health innovation initiatives
Prompt diagnosis of disease is a key determinant in reducing mortality, improving patient care and decreasing healthcare costs. Despite the success of classical machine learning (ML) in improving predictive modeling across oncology, cardiology, and neurology, growing data dimensionality and computational complexity remain ongoing barriers. Quantum computing based on superposition and entanglement is a promising computational paradigm that shows potential advantages in high-dimensional pattern recognition and kernel-based learning. This review aims to systematically summarize preliminary work on quantum machine learning (QML) with empirical applications for early disease diagnosis, focusing on its theoretical underpinnings in addition to its algorithmic design and use in healthcare. We then frame the discussion with respect to quantum support vector machines and variational quantum classifiers, quantum kernels, as well as hybrid quantum–classical architectures. We further evaluate existing hardware constraints in the noisy intermediate-scale quantum (NISQ) era and appraise translational maturity for integration into public health. While clinical deployment is still far from broad, hybrid QMLs are proving useful in low-data and complex-feature contexts. We end with research challenges, regulatory guidance, and strategic directions towards enabling quantum-enhanced precision diagnostics aligned with U.S. public health innovation initiatives.